Transcatheter edge-to-edge repair of anterior mitral flail through a dehisced annuloplasty ring

Edwin C Ho1, Naveed Ahmed1, Kim A Connelly1

  • 1Division of Cardiology, St. Michael's Hospital, Toronto, Canada.

Insights

Mitral annuloplasty ring dehiscence can cause recurrent mitral regurgitation (MR). The MitraClip device was successfully used to treat this condition in a high-risk patient, offering a new therapeutic option.

Area of Science:

  • Cardiovascular Surgery
  • Interventional Cardiology

Background:

  • Recurrent mitral regurgitation (MR) following mitral annuloplasty is a rare but serious complication.
  • Annuloplasty ring dehiscence can lead to significant heart failure and increased mortality.
  • Surgical re-intervention for this complication carries a high risk.

Observation:

  • A patient with prohibitive surgical risk presented with recurrent primary MR due to mitral annuloplasty ring dehiscence.
  • This case represents the initial use of the MitraClip device for this specific clinical scenario.

Findings:

  • The MitraClip procedure was successfully applied to address the recurrent MR caused by ring dehiscence.
  • This intervention effectively managed the mitral regurgitation in a patient unsuitable for conventional surgery.

Implications:

  • The MitraClip offers a potentially life-saving alternative for patients with recurrent MR from annuloplasty ring dehiscence and high surgical risk.
  • This case expands the indications for transcatheter mitral valve repair in complex cardiac conditions.
  • Further research is warranted to evaluate the long-term efficacy and safety of MitraClip in this patient population.

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
376
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
450
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
403
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
966